Back
Guardant Health Vs. Bowman Consulting Group Industry Stock Comparison
Buy
66
GH
Guardant Health
Last Price:
19.48
Seasonality Move:
23.23%
Sell
35
BWMN
Bowman Consulting Group
Last Price:
32.38
Seasonality Move:
-0.83%
Buy
66
Guardant Health (GH)
is a Buy
Is Guardant Health a Buy, Sell or Hold?
- The current Guardant Health [GH] share price is $19.44. The Score for GH is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- GH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Bowman Consulting Group (BWMN)
is a Sell
Is Bowman Consulting Group a Buy, Sell or Hold?
- The current Bowman Consulting Group [BWMN] share price is $32.29. The Score for BWMN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- BWMN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GH Stock Price Chart
What is Guardant Health's stock price today?
-
The Guardant Health share price today is $19.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GH is experiencing buying pressure, which is a positive indicator for future bullish movement.
BWMN Stock Price Chart
What is Bowman Consulting Group's stock price today?
-
The Bowman Consulting Group share price today is $32.29
The current trend is relatively stagnant and BWMN is experiencing slight selling pressure.
GH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 58.12 | Buy |
| Chaikin Money Flow: | 2523289 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.01 - 18.95) | Buy |
| Bollinger Bands (100): | (17.73 - 24.51) | Sell |
BWMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.45 | Sell |
| Relative Strength Index (14 RSI): | 49.62 | Sell |
| Chaikin Money Flow: | -2623 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.61 - 32.65) | Buy |
| Bollinger Bands (100): | (30.83 - 36.55) | Sell |
GH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.72 | Buy |
| 20-day SMA: | 17.81 | Buy |
| 50-day SMA: | 18.33 | Buy |
| 200-day SMA: | 25.51 | Sell |
| 8-day EMA: | 18.72 | Buy |
| 20-day EMA: | 18.34 | Buy |
| 50-day EMA: | 18.92 | Buy |
| 200-day EMA: | 24.43 | Sell |
BWMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.69 | Buy |
| 20-day SMA: | 31.43 | Buy |
| 50-day SMA: | 34.07 | Sell |
| 200-day SMA: | 31.55 | Buy |
| 8-day EMA: | 31.92 | Buy |
| 20-day EMA: | 32.08 | Buy |
| 50-day EMA: | 32.98 | Sell |
| 200-day EMA: | 31.6 | Buy |
Guardant Health Earnings Growth & GH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.05 per share, an increase this year of $0.58 per share, and an increase next year of $0.32 per share.
Bowman Consulting Group Earnings Growth & BWMN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.46 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.66 per share, and an increase next year of $0.34 per share.
Guardant Health Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bowman Consulting Group Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||